Creative Medical Technology Holdings, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Creative Medical Technology Holdings, Inc. is holding a special meeting on August 28, 2026, to vote on increasing authorized shares and approving the exercise of investor warrants.
NASDAQ
Creative Medical Technology Holdings, Inc. is holding a Special Meeting on December 26, 2025, to seek stockholder approval for the full exercise of warrants covering 2,790,340 shares of common stock.
NASDAQ
Creative Medical Technology Holdings, Inc. announced its 2025 Annual Meeting of Stockholders to be held on December 18, 2025, to vote on director elections, executive compensation, and auditor ratification.
NASDAQ
Creative Medical Technology Holdings is holding a special meeting on May 5, 2025, to seek stockholder approval for the exercise of warrants covering 1,799,774 shares of common stock to comply with Nasdaq Listing Rule 5635(d).
NASDAQ
Creative Medical Technology Holdings is holding a special meeting to seek stockholder approval for increasing authorized shares and approving the exercise of investor warrants.
NASDAQ
Creative Medical Technology Holdings is holding its 2024 Annual Meeting of Stockholders on July 19, 2024, to vote on key proposals including increasing authorized shares, electing directors, and ratifying executive compensation.